Hepatology
Applied Evidence
Non-alcoholic fatty liver disease: What’s in our arsenal?
Lifestyle changes and metabolic syndrome management are the best interventions for NAFLD. Less clear is which agents to use for liver-directed...
News
Test all kidney transplant patients for hepatitis E
All kidney transplant recipients with abnormal liver function test results should be tested for hepatitis E virus RNA, according to a recent...
News
Birth-cohort HCV testing misses one-quarter of infections
Key clinical point: CDC recommendations for birth-cohort and high-risk screening for hepatitis C infection may miss one-quarter of infections....
Conference Coverage
Lessons from the Indiana HIV/HCV outbreak
News
FDA revises Olysio label after adverse reactions in East Asian patients
The U.S. Food and Drug Administration has revised labeling for a hepatitis C drug after adverse reactions were experienced by East Asian patients...
Patient Information
FDA approves new treatment for chronic HCV genotypes 1 and 4
News
MRI topped transient elastography for staging nonalcoholic fatty liver disease
Two magnetic resonance imaging techniques topped transient elastography for diagnosing hepatic fibrosis and steatosis in patients with...
Article
The microbiome in celiac disease: Beyond diet-genetic interactions
Article
Celiac disease: Managing a multisystem disorder
News
Portal inflammation in pediatric NAFLD linked to fibrosis
Portal inflammation in children with nonalcoholic fatty liver disease is associated with a more than threefold greater risk of more advanced...
News
Electronic program reduces cirrhosis readmission rates
An electronic quality improvement initiative for patients with cirrhosis has achieved significant reductions in 30-day readmission rates,...